Efficacy of Tocilizumab on Patients With COVID-19

NCT04356937 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

243

Enrollment

OTHER

Sponsor class

Conditions

SARS-CoV 2

Interventions

DRUG: Tocilizumab
DRUG: Placebos

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]